Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC
EAGLE PHARMACEUTICALS, INC. |
SLAYBACK PHARMA LLC, APOTEX INC. and APOTEX CORP. |
23-1110 |
November 2, 2022 |
U.S. Court of Appeals, Federal Circuit |
Patent - (ANDA) (Fed. Qst.) |
Opinions
We have the following opinions for this case:
Description |
---|
EAGLE PHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC |
Docket Report
This docket was last retrieved on December 19, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 22 **TEXT ONLY** ORDER granting motion to extend time to file brief [ # 21 ] filed by Appellees Apotex Inc., Apotex Corp. and Slayback Pharma LLC. The response brief is due 01/18/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [891318] [KMH] [Entered: 12/19/2022 09:35 AM] |
Filing 21 MOTION of Appellees Slayback Pharma LLC, Apotex Inc. and Apotex Corp. to extend the time to 01/18/2023 to file brief. Service: 12/13/2022 by email. [890489] [23-1110] [Deepro Mukerjee] [Entered: 12/13/2022 07:05 PM] |
Filing 20 MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED by Appellant Eagle Pharmaceuticals, Inc.. Service: 12/09/2022 by email. [889793] --[Edited 12/19/2022 by KMH - compliance review complete] [Daniel Brown] [Entered: 12/09/2022 06:27 PM] |
Filing 19 Amended Certificate of Interest for Appellant Eagle Pharmaceuticals, Inc.. Service: 12/09/2022 by email. [889790] [23-1110] [Daniel Brown] [Entered: 12/09/2022 06:22 PM] |
Filing 18 NOTICE OF NON-COMPLIANCE: The submission of Appellant Eagle Pharmaceuticals, Inc., Principal Brief of Appellant [ # 15 ], is not in compliance with the rules of this court (see attached). Compliant document due on 12/16/2022. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [889711] [CAB] [Entered: 12/09/2022 03:14 PM] |
Filing 17 Corrected Entry of appearance for Constance S. Huttner; Roy Wepner; Jason Lief; Beth Finkelstein as counsel for Appellee Slayback Pharma LLC. Service: 11/28/2022 by email. [886563] [23-1110] [Constance Huttner] [Entered: 11/28/2022 09:52 AM] |
Filing 16 Amended Certificate of Interest for Appellant Eagle Pharmaceuticals, Inc.. Service: 11/25/2022 by email. [886527] [23-1110] [Daniel Brown] [Entered: 11/25/2022 10:36 PM] |
Filing 15 OPENING BRIEF FILED by Appellant Eagle Pharmaceuticals, Inc.. Service: 11/25/2022 by email. [886526] [23-1110] This document is non-compliant. See Doc No. [ # 18 ] [Daniel Brown] [Entered: 11/25/2022 10:31 PM] |
Filing 14 Corrected Entry of appearance for Daniel G. Brown;Gregory G. Garre;Gabriel K. Bell;Michael Clemente;David F. Kowalski as counsel for Appellant Eagle Pharmaceuticals, Inc.. Service: 11/22/2022 by email. [886131] [23-1110] [Daniel Brown] [Entered: 11/22/2022 02:23 PM] |
Filing 13 NOTICE OF NON-COMPLIANCE: The submission of Appellant Eagle Pharmaceuticals, Inc. and Appellee Slayback Pharma LLC, Entry of Appearance [ # 12 ], [ # 2 ], is not in compliance with the rules of this court (see attached). Compliant document due on 12/01/2022. Service as of this date by the Clerk of Court. [885752] [KMH] [Entered: 11/22/2022 09:10 AM] |
Filing 12 Corrected Entry of appearance for Constance S. Huttner; Roy Wepner; Jason Lief; Beth Finkelstein as counsel for Appellee Slayback Pharma LLC. Service: 11/21/2022 by email. [885703] [23-1110] This document is non-compliant. See Doc No. [Constance Huttner] [Entered: 11/21/2022 08:56 PM] |
Filing 11 Notice of Correction to Doc No. [ # 5 ] for Appellee Slayback Pharma LLC. Service: 11/21/2022 by email. [885702] [23-1110] [Constance Huttner] [Entered: 11/21/2022 08:54 PM] |
Filing 10 Docketing Statement for the Appellees Apotex Inc. and Apotex Corp.. Service: 11/16/2022 by email. [884510] [23-1110] [Deepro Mukerjee] [Entered: 11/16/2022 03:26 PM] |
Filing 9 Certificate of Interest for Appellees Apotex Inc. and Apotex Corp.. Service: 11/16/2022 by email. [884509] [23-1110] [Deepro Mukerjee] [Entered: 11/16/2022 03:24 PM] |
Filing 8 Entry of appearance for Deepro Mukerjee;Lance Soderstrom;Jitendra Malik;Joseph Janusz;Christopher Ferenc as counsel for Appellees Apotex Inc. and Apotex Corp.. Service: 11/16/2022 by email. [884502] [23-1110] [Deepro Mukerjee] [Entered: 11/16/2022 03:19 PM] |
Filing 7 Docketing Statement for the Appellee Slayback Pharma LLC. Service: 11/16/2022 by email. [884474] [23-1110] [Constance Huttner] [Entered: 11/16/2022 02:14 PM] |
Filing 6 Certificate of Interest for Appellee Slayback Pharma LLC. Service: 11/16/2022 by email. [884472] [23-1110] [Constance Huttner] [Entered: 11/16/2022 02:13 PM] |
Filing 5 Entry of appearance for Constance S. Huttner; Roy Wepner; Jason Lief; Beth Finkelstein as counsel for Appellee Slayback Pharma LLC. Service: 11/16/2022 by email. [884471] [23-1110] [Constance Huttner] [Entered: 11/16/2022 02:12 PM] |
Filing 4 Docketing Statement for the Appellant Eagle Pharmaceuticals, Inc.. Service: 11/16/2022 by email. [884459] [23-1110] [Daniel Brown] [Entered: 11/16/2022 01:50 PM] |
Filing 3 Certificate of Interest for Appellant Eagle Pharmaceuticals, Inc.. Service: 11/16/2022 by email. [884457] [23-1110] [Daniel Brown] [Entered: 11/16/2022 01:48 PM] |
Filing 2 Entry of appearance for Daniel G. Brown;Gregory G. Garre;Gabriel K. Bell;Michael Clemente;David F. Kowalski as counsel for Appellant Eagle Pharmaceuticals, Inc.. Service: 11/16/2022 by email. [884456] [23-1110] This document is non-compliant. See Doc No. [ # 13 ] [Daniel Brown] [Entered: 11/16/2022 01:45 PM] |
Filing 1 Appeal docketed. Received: 10/27/2022. [881790] Entry of Appearance due 11/16/2022. Certificate of Interest is due on 11/16/2022. Docketing Statement due 11/16/2022. Appellant/Petitioner's brief is due 01/03/2023. [KMH] [Entered: 11/02/2022 03:04 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.